Table 1.
Patient recruited (PT) and expression datasets retrieved (PR) for this study.
| Patient (PT)/Profile (PR) | Sex | Age (Years) | Tissue sample | Pathology/Lesion type | Co-morbidities | Pharmacological therapy | Plasma lipid/Stenosis/ICR |
| PT1 | M | 50 | LAD | Ischemic/VII | Hypothyroidism | D;AAP;AC;HYR | +/> 75%/5 |
| PT2 | F | 68 | LAD;AB | Ischemic/VII | None | D;AC | +/> 75%/4.6 |
| PT3 | M | 66 | LAD;AB | Ischemic/VII | Cholecystectomy | AAP;HYR | =/> 75%/5 |
| PT4 | M | 64 | LAD;AB | Ischemic/VII | None | D;HYR | +/> 75%/5.2 |
| PT5 | M | 64 | LAD;AB | Ischemic/VI | PAH | D;ST;AAP;HYR | +/> 75%/4.9 |
| PT6 | M | 42 | LAD;AB | Ischemic/VII | None | D;HYR | +/> 75%/5.3 |
| PT7 | M | 53 | LAD;AB | Ischemic/VII | Stone Kidney | D;HYR;AAP | +/> 75%/5.1 |
| PT8 | M | 68 | LAD | Ischemic/VI | None | D;HYR;AAP | +/> 75%/5.2 |
| PT9 | M | 46 | LAD;AB | DCM/ctrl | None | D;AC | +/-/4.6 |
| PT10 | M | 48 | LAD;AB | DCM/ctrl | Kidney pathology | D;AC | =/-/4.7 |
| PT11 | F | 55 | LAD;AB | DCM/ctrl | Thyroidectomy | D;AC;CDR | =/-/4.5 |
| PT12 | F | 59 | LAD;AB | DCM/ctrl | None | BB;AC;AAP | =/-/3.2 |
| PT13 | M | 63 | LAD;AB | DCM/ctrl | None | ACEH;D;AC | =/-/3.6 |
| PT14 | M | 53 | LAD;AB | DCM/ctrl | None | ACEH;D;AAP | +/-/3.8 |
| PT15 | M | 62 | LAD | DCM/ctrl | Gilbert's syndrome | AAP | =/-/3.5 |
| PT16 | M | 61 | LAD | DCM/ctrl | None | ACEH;ST | =/-/3.5 |
| PT17 | F | 59 | LAD | DCM/ctrl | None | ACEH;AC;AAP | =/-/4.3 |
| PT18 | F | 41 | LAD | DCM/ctrl | None | D | =/-/3.9 |
| PT19 | M | 70 | AB | Ischemic/VII | T2D | D;HYR;SI | +/> 75%/5 |
| PT20 | M | 67 | AB | Ischemic/VII | Mitral insufficiency | None | =/> 75%/4.3 |
| PT21 | F | 82 | AB | Ischemic/VII | HY | None | +/> 75%/4.6 |
| PT22 | M | 63 | AB | Ischemic/VI | None | None | =/> 75%/4.8 |
| PT23 | M | 75 | AB | Ischemic/VI | None | ACEH;HYR | +/> 75%/5.2 |
| PT24 | M | 64 | AB | Ischemic/VII | PD | HYR;D;LD | +/> 75%/5.1 |
| PT25 | M | 75 | AB | Ischemic/VII | T2D;HY | SI;HYR | +/> 75%/5.2 |
| PT26 | M | 57 | AB | Ischemic/VII | T2D;HY | SI;HYR | +/> 75%/5.5 |
| PT27 | M | 66 | AB | Ischemic/VII | HY | HYR | +/> 75%/5.2 |
| PT28 | M | 69 | AB | Ischemic/VII | HY | HYR | +/> 75%/5 |
| PT29 | M | 51 | AB | Ischemic/VI | None | None | =/> 75%/4.8 |
| PT30 | F | 78 | AB | Ischemic/VII | HY | HYR | +/> 75%/4.5 |
| PT 31 | M | 75 | AB | Ischemic/VI | None | None | =/> 75%/5.1 |
| PR32* | M | 67 | Carotid | Ischemic | Acute bronchitis | NA | NA/75%/NA |
| PR33* | M | 67 | Carotid | Ischemic | Acute bronchitis | NA | NA/71%/NA |
| PR34* | F | 63 | Carotid | Ischemic | CAD;T2D;HY | NA | NA/75%/NA |
| PR35* | F | 63 | Carotid | Ischemic | CAD;T2D;HY | NA | NA/50%/NA |
| PR36* | F | 59 | Carotid | Ischemic | HY;HYCH | NA | NA/75%/NA |
| PR37* | F | 59 | Carotid | Ischemic | HY;HYCH | NA | NA/83%/NA |
| PR38* | F | 71 | Carotid | Ischemic | CAD;T2D;HY;HYCH;AD | NA | NA/70%/NA |
| PR39* | F | 71 | Carotid | Ischemic | CAD;T2D;HY;HYCH;AD | NA | NA/83%/NA |
| PR40† | NA | NA | Coronary | Normal | NA | NA | NA |
| PR41† | NA | NA | Coronary | Normal | NA | NA | NA |
| PR42† | NA | NA | Coronary | Normal | NA | NA | NA |
| PR43‡ | M | NA | Coronary | Normal | NA | NA | NA |
| PR44‡ | M | NA | Coronary | Normal | NA | NA | NA |
| PR45‡ | M | NA | Coronary | Normal | NA | NA | NA |
* PR of atherosclerotic carotids from E-MEXP-268, a study performed on carotid bilateral stenosis in which the two carotids (indicated by couple of consecutive numbers in the Table) of four independent patients have been analyzed. † PR of normal coronaries from GSE3526 (GSM80609, GSM80610, GSM80631). ‡ PR of normal coronaries from GSE7307 (GSM176115, GSM175820, GSM175821). ICR: index of cardiovascular risk; LAD: Left Anterior Descendent Coronary; AB: Arterial Blood; DCM/ctrl: Dilated Cardiomyopathy, used as pooled controls for microarray experiments; D: Diuretics; AAP: Anti-arrhythmics; AC: Anti-coagulants; HYR: Hypertension regulators; BB: Beta-blockers; ACEH: ACE inhibitors; ST: Statins; CDR: Cholesterol down-regulators; SI: Synthetic insulin; LD: Levodopa; PAH: Pulmonary hypertension; T2D: Type-2-diabetes; HY: Hypertension; HYCH: Hypercholesterolemia; PD: Parkinson's disease; AD: Artery disease; NA: not available.